18 May 2013
Keywords: par, sees, 2nd-qtr, sales, rocket, pharmaceuticals, saw
Article | 09 August 2004
Par Pharmaceuticals saw its revenues for the second quarter of 2004leap 83% to $212.5 million, led by a robust performance of the ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
9 August 2004
17 May 2013
© 2013 thepharmaletter.com